Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 7/20 | 0.65 |
| ▸ | TTR | P02766 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3286500 | 0.86 | GPR35 (0.61) | GPR35TTRALDH1A1KDM4EMEN1 | |
| SCHEMBL31226260 | 0.80 | ALDH1A1 (0.50) | GPR35ALDH1A1CYP3A4TDP1HPGD | |
| SCHEMBL2078816 | 0.80 | TTR (0.57) | GPR35TTRALDH1A1KDM4EMEN1 | |
| SCHEMBL3858194 | 0.80 | TTR (0.67) | GPR35TTRALDH1A1CYP3A4KDM4E | |
| SCHEMBL9847876 | 0.80 | TSHR (0.44) | GPR35ALDH1A1CYP3A4TDP1HPGD | |
| SCHEMBL310420 | 0.80 | GPR35 (0.69) | GPR35TTRALDH1A1CYP3A4KDM4E | |
| SCHEMBL30807397 | 0.78 | GPR35 (1.00) | GPR35TTRALDH1A1CYP3A4KDM4E | |
| SCHEMBL2165473 | 0.78 | GPR35 (1.00) | GPR35TTRALDH1A1CYP3A4KDM4E | |
| SCHEMBL13113132 | 0.78 | TTR (0.51) | GPR35TTRALDH1A1KDM4EMEN1 | |
| SCHEMBL3207603 | 0.77 | GPR35 (0.44) | GPR35TTRALDH1A1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4031249-A | TREMATODES, NEMATODES, FASCIOLA SP | ICI AUSTRALIA LIMITED (AU) | 1977-06-21 | — | — | US | claimed |
| EP-3080115-B1 | FUSED IMIDAZOLE AND PYRAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2019-05-08 | — | — | EP | disclosed |
| US-9868749-B2 | Fused imidazole and pyrazole derivatives as modulators of TNF activity | UCB BIOPHARMA SPRL (BE) | 2018-01-16 | — | — | US | disclosed |
| EP-3080115-A1 | FUSED IMIDAZOLE AND PYRAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SPRL (BE) | 2016-10-19 | — | — | EP | disclosed |
| US-20160297837-A1 | Fused Imidazole and Pyrazole Derivatives As Modulators of TNF Activity | EVOTEC (UK) LTD. (GB) | 2016-10-13 | — | — | US | disclosed |
| WO-2015086506-A1 | FUSED IMIDAZOLE AND PYRAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2015-06-18 | — | — | WO | disclosed |
| US-8883826-B2 | Alkynyl derivatives as modulators of metabotropic glutamate receptors | ADDEX PHARMA SA (CH) | 2014-11-11 | — | — | US | disclosed |
| US-8674106-B2 | Alkynyl derivatives as modulators of metabotropic glutamate receptors | ADDEX PHARMA SA (CH) | 2014-03-18 | — | — | US | disclosed |
| US-20130178631-A1 | NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | ADDEX PHARMA SA (CH) | 2013-07-11 | — | — | US | disclosed |
| CN-102993084-A | Alkynyl derivatives as modulators of metabotropic glutamate receptors | ADDEX PHARMACEUTICALS SA | 2013-03-27 | — | — | CN | disclosed |
| CN-1325267-A | Fused-benzene derivatives useful as herbicides | ISHIHARA SANGYO KAISHA (JP) | 2001-12-05 | — | — | CN | disclosed |
| EP-1111993-A1 | FUSED-BENZENE DERIVATIVES USEFUL AS HERBICIDES | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2001-07-04 | — | — | EP | disclosed |
| US-6162790-A | OLIGOPEPTIDES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2000-12-19 | — | — | US | disclosed |
| WO-2000013508-A1 | FUSED-BENZENE DERIVATIVES USEFUL AS HERBICIDES | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2000-03-16 | — | — | WO | disclosed |
| CN-1207743-A | Inhibitors of interleukin-1 beta converting enzyme | VERTEX PHARMA (US) | 1999-02-10 | — | — | CN | disclosed |
| US-5843904-A | Inhibitors of interleukin-1βconverting enzyme | VERTEX PHARMACEUTICALS, INC. (US) | 1998-12-01 | — | — | US | disclosed |
| EP-0876395-A1 | INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME | Vertex Pharmaceuticals Incorporated (US) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997022618-A1 | INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1997-06-26 | — | — | WO | disclosed |
| US-4031249-A | TREMATODES, NEMATODES, FASCIOLA SP | ICI AUSTRALIA LIMITED (AU) | 1977-06-21 | — | — | US | disclosed |
| US-4031249-A | TREMATODES, NEMATODES, FASCIOLA SP | ICI AUSTRALIA LIMITED (AU) | 1977-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178631-A1 | NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | GRM5, GRM1, GRM2 | GPR35 36/4885TTR 4391/4885ALDH1A1 2153/4885 |
| US-20160297837-A1 | Fused Imidazole and Pyrazole Derivatives As Modulators of TNF Activity | TNF, TNFRSF1A, TNFRSF9 | GPR35 1405/4885TTR 1703/4885ALDH1A1 1610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.